Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
This blog looks at the impact of orbit and operating frequency on the types of IoT service a satellite operator can deliver. Paying attention to IoT network topology and air-interface protocols will enable all operators to make the most of the dish in front of them, says Steve Baker.
Robotic surgery is a hot topic: the concept is popular with patients, on the minds of industry leaders, and seen as the future of surgery by many investors. Too often, robotic-assisted surgery is equated with precision, and precision with improved clinical outcomes. Excitement is driving investment and a growing number of robotic-assisted surgery companies. But, in basic terms, what is a good innovation strategy in surgery… and is it robotics?
Intravenous delivery remains the dominant paradigm in oncology, but even with precision medicine few drugs pass late stage clinical trials. Karthik Chellappan proposes that early exploration of better administration routes could make all the difference.
When working with machine learning tools and algorithms, we often assume that only the machine is learning. Not so, argues Mark Hsieh. To achieve maximum value, we need to learn from the results generated by algorithms to better understand the problem we are trying to solve, for example in predicting disease progression in diabetes.
TTP's Desktop Biology team will be exhibiting on booth 3383 at AACC 2019. See how we can advance your biology.
TTP plc, a leading independent technology and product development company, and the Medical Research Council (MRC) will co-fund a PhD student at Imperial College London to develop new tools for production of cell therapies and cell-based products.
TTP plc (TTP), a leading independent technology and product development company, has announced today that it has partnered with Quotient Ltd to develop and implement a state-of-the-art manufacturing facility for Quotient’s proprietary MosaiQ™ system.
Cellular Highways, TTP plc’s most recent spin out, is developing a new generation of automated high-throughput cell sorting instruments for research, diagnostic and therapeutic applications. Powered by a new microfluidic cell sorter technology, our instruments will reduce the cost and complexity of cell sorting and achieve far higher throughput than existing platforms.
